永安药业最新股东户数环比下降6.48%

Group 1 - The core point of the article highlights that Yong'an Pharmaceutical has experienced a decline in the number of shareholders, with a decrease of 4,140 shareholders to a total of 59,707, representing a 6.48% drop compared to the previous period [2] - The company's stock price closed at 19.70 yuan, down 1.60%, and has seen a cumulative decline of 16.77% since the concentration of shares began, with 4 days of increase and 10 days of decrease in trading [2] - In the first quarter, Yong'an Pharmaceutical reported a revenue of 171 million yuan, a year-on-year decrease of 12.96%, and a net loss of 4.37 million yuan, a year-on-year decline of 115.23%, with a basic earnings per share of -0.0151 yuan [2] Group 2 - On July 15, the company released a half-year performance forecast, estimating a net profit between 10.02 million yuan and 15.02 million yuan, indicating a change range of -80.91% to -71.39% [2]